4//SEC Filing
Fernandes Peter 4
Accession 0001600132-19-000132
CIK 0001600132other
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 4:53 PM ET
Size
5.4 KB
Accession
0001600132-19-000132
Insider Transaction Report
Form 4
Fernandes Peter
Chief Regulatory Officer
Transactions
- Award
Stock Option (right to buy)
2019-09-26+175,500→ 470,290 totalExercise: $0.50Exp: 2029-09-26→ Common Stock (175,500 underlying)
Footnotes (1)
- [F1]1. This option was granted on September 26, 2019. This option vests in quarterly installments over a four-years period from the date of grant.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeother
Related Parties
1- filerCIK 0001642618
Filing Metadata
- Form type
- 4
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 4:53 PM ET
- Size
- 5.4 KB